SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011898
Filing Date
2024-08-12
Accepted
2024-08-12 16:10:33
Documents
76
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240630x10q.htm   iXBRL 10-Q 1705969
2 EX-10.1 tmb-20240630xex10d1.htm EX-10.1 104455
3 EX-31.1 tmb-20240630xex31d1.htm EX-31.1 14518
4 EX-31.2 tmb-20240630xex31d2.htm EX-31.2 14556
5 EX-32.1 tmb-20240630xex32d1.htm EX-32.1 7793
6 EX-32.2 tmb-20240630xex32d2.htm EX-32.2 7861
  Complete submission text file 0001558370-24-011898.txt   6544623

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20240630.xsd EX-101.SCH 48212
8 EX-101.CAL tmb-20240630_cal.xml EX-101.CAL 43310
9 EX-101.DEF tmb-20240630_def.xml EX-101.DEF 189054
10 EX-101.LAB tmb-20240630_lab.xml EX-101.LAB 391095
11 EX-101.PRE tmb-20240630_pre.xml EX-101.PRE 326165
79 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240630x10q_htm.xml XML 852158
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 241196860
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)